What if you invested $1,000 in Novo Nordisk in 2015? (Inflation-Adjusted)
NVO · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionNominal returns can be misleading over long periods. $1,000 in Novo Nordisk in 2015 became $2,591 by 2026. Over those 12 years, cumulative CPI inflation reached 39% (BLS CPI-U). Restating the return in constant purchasing power, the real value of your gain in 2015 dollars is $1,864, a real annualized return of +5.6%.
Nominal final value
$2,591
+159.1% total return
Real value (2015 dollars)
$1,864
+86.4% real total return
Real annualized return
+5.6%
vs. +8.6% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Novo Nordisk since 2015, values in constant 2015 dollars
| Year | Nominal Value | Real Value (2015 $) |
|---|---|---|
| 2015 | $1,000 | $1,000 |
| 2016 | $1,273 | $1,255 |
| 2017 | $847 | $817 |
| 2018 | $1,339 | $1,253 |
| 2019 | $1,162 | $1,061 |
| 2020 | $1,540 | $1,385 |
| 2021 | $1,800 | $1,541 |
| 2022 | $2,634 | $2,066 |
| 2023 | $3,716 | $2,807 |
| 2024 | $6,223 | $4,567 |
| 2025 | $4,631 | $3,332 |
| 2026 | $3,349 | $2,409 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2015 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.